Skip to main content
. Author manuscript; available in PMC: 2016 Aug 2.
Published in final edited form as: Lancet Oncol. 2012 Jun 14;13(7):734–742. doi: 10.1016/S1470-2045(12)70226-7

Table 2.

Side-effects and toxic effects*

Placebo (n=1623) Clodronate (n=1612)
Toxicity Grade 3

n (%)
Grade 4

n (%)
Grade 5

n (%)
Grade 3

n (%)
Grade 4

n (%)
Grade 5

n (%)
Overall 223 (14) 110 (7) 12 (1) 247 (15) 85 (5) 5 (<1)
Diarrhea 10 (<1) 0 0 27 (2) 1 (<1) 0
ALT/AST 10 (<1) 2 (<1) 0 21 (1) 2 (<1) 0
Hypocalcemia 2 (<1) 0 0 1 (<1) 0 0
Creatinine 0 0 0 3 (<1) 1 (<1) 0
Thrombosis or embolism 17 (1) 13 (<1) 0 13 (1) 4 (<1) 0
Pancreatitis 1 (<1) 0 0 5 (<1) 0 0

Based on the National Cancer Institute’s common toxicity criteria, version 4.0. ALT=alanine aminotransferase. AST=aspartate aminotransferase.

*

Information on toxic effects was available for 97% (3235/3323) of patients enrolled in the study.